Literature DB >> 33738788

For whom the disc tolls: intervertebral disc degeneration, back pain and toll-like receptors.

D G Bisson, M Mannarino, R Racine, L Haglund1.   

Abstract

Intervertebral disc (IVD) degeneration is characterised by catabolic and inflammatory processes that contribute largely to tissue degradation and chronic back pain. The disc cells are responsible for the pathological production of pro-inflammatory cytokines and catabolic enzymes leading to degeneration. However, this phenotypical change is poorly understood. Growing evidence in animal and human studies implicates Toll-like receptors (TLR) and their activation through danger-associated alarmins, found increasingly in degenerating IVDs. TLR signalling results in the release of pro-inflammatory cytokines and proteolytic enzymes that can directly cause IVD degeneration and back pain. This review aims to summarise the current literature on TLR activation in IVD degeneration and discuss potential treatment modalities to alleviate the inflammatory phenotype of disc cells in order to arrest IVD degeneration and back pain.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33738788     DOI: 10.22203/eCM.v041a23

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  3 in total

Review 1.  New Progress in Basic Research of Macrophages in the Pathogenesis and Treatment of Low Back Pain.

Authors:  Miaoheng Yan; Zongmian Song; Hongwei Kou; Guowei Shang; Chunfeng Shang; Xiangrong Chen; Yanhui Ji; Deming Bao; Tian Cheng; Jinfeng Li; Xiao Lv; Hongjian Liu; Songfeng Chen
Journal:  Front Cell Dev Biol       Date:  2022-05-20

Review 2.  Computational Modeling Intervertebral Disc Pathophysiology: A Review.

Authors:  Mallory Volz; Shady Elmasry; Alicia R Jackson; Francesco Travascio
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

3.  HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages.

Authors:  Shuo Zhang; Peng Wang; Binwu Hu; Weijian Liu; Xiao Lv; Songfeng Chen; Zengwu Shao
Journal:  Front Cell Dev Biol       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.